The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
MMA CAPITAL HOLDINGS INC COM 55315D105 2,532 75,652 SH   SOLE   75,652 0 0
ONCONOVA THERAPEUTICS INC COM NEW 68232V405 2,318 813,434 SH   SOLE   813,434 0 0
ONCONOVA THERAPEUTICS INC *W EXP 07/07/202 68232V116 70 390,624 SH   SOLE   390,624 0 0